BMO Capital Markets adjusted their outlook on DuPont (NYSE:DD), increasing the price target from the previous $105.00 to a ...

Arvinas (NASDAQ:ARVN – Get Free Report)‘s stock had its “outperform” rating reiterated by BMO Capital Markets in a research report issued to clients and investors on Wednesday,Benzinga reports. They ...

BMO Capital Markets maintained its Market Perform rating on Keyera Corp . (TSX:KEY:CN) (OTC: KEYUF), with a steady price target of Cdn$45.50. The stock experienced a notable increase at the opening of ...

Stocks came within a striking distance of their all-time highs while the dollar got hit as President Donald Trump moved to ...

BMO Capital raised the firm’s price target on CAE (CAE) to C$39 from C$38 and keeps an Outperform rating on the shares.Maximize Your Portfolio ...

BMO Capital Markets downgraded shares of Fluence Energy (NASDAQ:FLNC – Free Report) from an outperform rating to a market perform rating in a research note released on Tuesday morning, MarketBeat.com ...

Wednesday afternoon's sale of $42 billion in 10-year notes tailed by 1 basis point and was met with non-dealer bidding that was slightly below average, according to BMO Capital Markets strategist Vail ...

Jan 13 (Reuters) - BMO Capital Markets (BMO.TO), opens new tab agreed to pay more than $40 million to settle U.S. Securities and Exchange Commission charges it failed to properly supervise ...

BMO Capital analyst Evan Seigerman lowered the firm’s price target on Biogen (BIIB) to $139 from $156 and keeps a Market Perform rating on the ...

Signs of resurgent inflation shown in January's consumer-price index can't be "easily explained away" by seasonal factors, and pressure will build on the Federal Reserve to stay on hold for a ...